Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ECO-04601 demonstrates broad antitumor activity in various tumor cell lines

March 31, 2004

RGB-286199, a potent, broad-spectrum cyclin-dependent kinase inhibitor

March 31, 2004

Doxazosin reduces bladder cancer tumor growth in vivo

March 31, 2004

Enhancement of paclitaxel anticancer activity with HSP70 inducer STA-4783

March 31, 2004

Nereus presents data on NPI-0052, a novel, oral proteasome inhibitor

March 31, 2004

Potent cytotoxic nucleoside for HCC therapy

March 31, 2004

G-protein-coupled receptor 45 possible target for treatment of cancer, other disorders

March 31, 2004

AEG-35156 enters phase I trials

March 31, 2004

Cloretazine enters phase II AML/MDS trial

March 31, 2004

Orathecin NDA accepted for filing

March 31, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...